Loading...
Loading...
Contributors:
Dataset URI:
10.3389/fimmu.2026.1769388.s005BackgroundThe crosstalk between intestinal epithelial cells (IEC) and CD4+ T-cells is essential for the maintenance of mucosal homeostasis, but its role in governing HIV-1 latency versus reactivation in gut-homing/resident T-cells remains poorly documented. We previously demonstrated that the Th17-lineage cytokine IL-17A transcriptionally reprograms IEC for promoting viral outgrowth in CD4+ T-cells of antiretroviral therapy (ART)-treated people with HIV-1 (PWH). These effects coincided with the downregulation of IL-32, a cytokine with documented antiviral properties and identified as a marker for HIV-1 disease progression and cardiovascular disease risk. Here, we aimed to identify modulators of IL-32 expression and to define the impact of IEC expressing IL-32 on HIV-1 outgrowth in neighboring CD4+ T-cells carrying viral reservoirs.MethodsHT-29 IEC were activated with TNF and/or IL-22, IL-26, all-trans retinoic acid (ATRA) and rosiglitazone (RGZ). CRISPR/Cas9 gene editing was used to knockout (KO) IL32 in IEC, with efficiency/off-target effect assessments performed using TIDE and whole-genome RNA-Sequencing. IL-32β/γ/ϵ mRNA/protein were quantified by RT-PCR/ELISA. An IEC-based viral outgrowth assay (VOA) was performed with CD4+ T-cells of ART-treated PWH. Soluble/intracellular HIV-p24 levels were measured by ELISA/flow cytometry.ResultsIn combination with TNF, IL-22 upregulated IL-32β/ϵ, RGZ increased IL-32β, ATRA decreased IL-32β/γ/ϵ, while IL-26 had no impact in IEC. HIV-1 outgrowth in IEC:T-cell co-cultures was not affected by IL-22/RGZ/ATRA-mediated changes in IL-32 expression. The analysis of differentially expressed genes in control versus IL32KO IEC revealed minor differences in transcriptional profiles before/after exposure to TNF, while the IL-32 mRNA/protein expression was induced by TNF in control but not IL32KO IEC. Finally, TNF-activated control versus IL32KO IEC supported with similar efficacy HIV-1 outgrowth in CD4+ T-cells of PWH.ConclusionsWe identified IL-22, ATRA and RGZ as novel regulators of IL-32 expression in TNF-primed IEC and demonstrated that pharmacological and genetic modulation of IL-32 expression in IEC has no major impact on HIV-1 outgrowth from co-cultured CD4+ T-cells of ART-treated PWH carrying viral reservoirs. By excluding its role in modulating HIV reservoir latency/reactivation at intestinal barrier level, these results support the idea of testing the potential use of IL-32 as a novel therapeutic target to reduce comorbidities in ART-treated PWH.
Keyword(s):
all-trans retinoic acid; antiretroviral therapy; CD4+ T-cells; CRISPR/Cas9; Genetic Immunology.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)